David Goldberg, MD
MOHS-Micrographic Surgery · Hackensack, NJNPI 1528001583
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (57.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 40 manufacturers reported payments, led by AbbVie at 47.8% of the total. Reporting peaked in 2023 at $219,433 and has fallen 60.0% since, to $87,674 in 2025. Among mohs-micrographic surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 314 payments — averaging $2612.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$392K
- Galderma Laboratories, L.p.$120K
- Sensus Healthcare, Inc.$92K
- Musculoskeletal Transplant Foundation Inc.$86K
- Lumenis, Inc$35K
- Sun Pharmaceutical Industries Inc.$28K
- plus $69K from 34 others
Across 139 payments — averaging $6158.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- H. Lundbeck A S$180K
- AbbVie$170K
- Mindera Corp$124K
- Sun Pharmaceutical Industries Inc.$95K
- Sweetbio, Inc.$61K
- Musculoskeletal Transplant Foundation Inc.$50K
- plus $176K from 8 others
What the payments were for
- Consulting fees$165,49420%
- Speaking & faculty fees$155,60619%
- Grants$473,90058%
- Travel & lodging$7,3211%
- Food & beverage$9,3581%
- Education$7,0001%
- Other$1,5870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$820,266 in reported general payments places this provider in the 95th percentile of 30 mohs-micrographic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 64 | $1,015 |
| Mupirocin | 82 | $651 |
| Doxycycline Hyclate | 14 | $290 |
| Hydrocortisone | 25 | $123 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Hackensack
- David CioconHackensack$938
- Shikha RaoHackensack$402
- Marc GlashoferWest Orange$175K
- Kehua LiSewell$22K
- Steven WangBasking Ridge$11K
- John VinePrinceton$8K
- Lian Jie LiPhillipsburg$7K
- David NajarianRandolph$5K
- Parth PatelBridgewater$4K
- Shreya PatelWest Orange$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.